369 related articles for article (PubMed ID: 15994922)
41. Ultraviolet A irradiation inhibits thymus and activation-regulated chemokine (TARC/CCL17) production by a human keratinocyte HaCaT cell line.
Zheng X; Nakamura K; Tojo M; Akiba H; Oyama N; Nishibu A; Kaneko F; Tsunemi Y; Kakinuma T; Saeki H; Tamaki K
Eur J Dermatol; 2003; 13(4):348-53. PubMed ID: 12948914
[TBL] [Abstract][Full Text] [Related]
42. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
43. Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW; Shafat I; Ben Barak A; Shalom RB; Vlodavsky I; Ilan N
Pediatr Hematol Oncol; 2009 Jun; 26(4):157-64. PubMed ID: 19437318
[TBL] [Abstract][Full Text] [Related]
44. Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.
Shimabukuro-Vornhagen A; Haverkamp H; Engert A; Balleisen L; Majunke P; Heil G; Eich HT; Stein H; Diehl V; Josting A
J Clin Oncol; 2005 Aug; 23(24):5739-45. PubMed ID: 16009944
[TBL] [Abstract][Full Text] [Related]
45. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity.
Ezzat MH; Sallam MA; Shaheen KY
Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860
[TBL] [Abstract][Full Text] [Related]
46. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
47. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
Jones K; Vari F; Keane C; Crooks P; Nourse JP; Seymour LA; Gottlieb D; Ritchie D; Gill D; Gandhi MK
Clin Cancer Res; 2013 Feb; 19(3):731-42. PubMed ID: 23224400
[TBL] [Abstract][Full Text] [Related]
48. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
49. Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.
Nogová L; Reineke T; Brillant C; Sieniawski M; Rüdiger T; Josting A; Bredenfeld H; Skripnitchenko R; Müller RP; Müller-Hermelink HK; Diehl V; Engert A;
J Clin Oncol; 2008 Jan; 26(3):434-9. PubMed ID: 18086799
[TBL] [Abstract][Full Text] [Related]
50. CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.
Vermont CL; Hazelzet JA; de Kleijn ED; van den Dobbelsteen GP; de Groot R
Crit Care; 2006 Feb; 10(1):R33. PubMed ID: 16507164
[TBL] [Abstract][Full Text] [Related]
51. Early serum TARC reduction predicts prognosis in advanced-stage Hodgkin lymphoma patients treated with a PET-adapted strategy.
Viviani S; Mazzocchi A; Pavoni C; Taverna F; Rossi A; Patti C; Romano A; Trentin L; Sorasio R; Guidetti A; Gottardi D; Tarella C; Cimminiello M; Zanotti R; Farina L; Ferreri AJM; Galbiati M; Corradini P; Gianni AM; Gallamini A; Rambaldi A
Hematol Oncol; 2020 Oct; 38(4):501-508. PubMed ID: 32602970
[TBL] [Abstract][Full Text] [Related]
52. Antiphospholipid antibodies may be a new prognostic parameter in aggressive non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Monselise Y; Lahav J; Stark P; Prokocimer M; Nativ HM; Kirgner I; Pazgal I; Shaklai M
Eur J Haematol; 2006 May; 76(5):384-91. PubMed ID: 16466368
[TBL] [Abstract][Full Text] [Related]
53. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease.
Portlock CS; Donnelly GB; Qin J; Straus D; Yahalom J; Zelenetz A; Noy A; O'Connor O; Horwitz S; Moskowitz C; Filippa DA
Br J Haematol; 2004 Jun; 125(6):701-8. PubMed ID: 15180859
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
55. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
56. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
57. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary T(H)2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis.
Hartl D; Griese M; Kappler M; Zissel G; Reinhardt D; Rebhan C; Schendel DJ; Krauss-Etschmann S
J Allergy Clin Immunol; 2006 Jan; 117(1):204-11. PubMed ID: 16387607
[TBL] [Abstract][Full Text] [Related]
59. The role of high-dose therapy and autologous stem cell transplantation in patients with primary refractory Hodgkin's lymphoma: a report from the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Morabito F; Stelitano C; Luminari S; Mammi C; Marcheselli L; Callea V; Gentile M; Polimeno G; Merli F; Molica S; Gobbi P; Angrilli F; Brugiatelli M; Federico M
Bone Marrow Transplant; 2006 Feb; 37(3):283-8. PubMed ID: 16327815
[TBL] [Abstract][Full Text] [Related]
60. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]